Guideline Resources
COVID-19 Symptom Eval | 2020 CDC, NIH, WHO Guidance Synthesis
Key Points
Non-resp sx may precede resp sx. Sx: fever, cough (+/- sputum), fatigue, anorexia, myalgia, dyspnea, sore throat, nasal congestion, diarrhea, N/V, anosmia, dysgeusia, HA, dizziness, stroke, etc. MIS-C (child, young adult): confusion/unable to awaken, severe abdo pain, cyanosis, rash, etc. Asymptomatic: 40% overall; 16%-45% of children; ~½ of SNF pts a-/pre-symptomatic. Persistent sx: fatigue, joint/chest pain, palpitations, SOB, anxiety/depression, HA, sensory/cognitive issues, etc. CDC Clinician On-Call: 800-232-4636.
Choose Patient Type
Based on multiple guidelines/recommendations from specialty societies/government agencies.
Epocrates Guideline Synopsis Last Update: Jan 12, 2021
Publication Year:
BMI body mass index
BP blood pressure
CAD coronary artery disease
CKD chronic kidney disease
CRP C-reactive protein
DM diabetes mellitus
GI gastrointestinal
HA headache
HF heart failure
HTN hypertension
IDSA Infectious Diseases Society of America
IL-6 interleukin 6
LDH lactic acid dehydrogenase
LN lymph nodes
MIS-C Multisystem Inflammatory Syndrome Children
NIH National Institutes of Health
N/V nausea/vomiting
PPE personal protective equipment
RA room air
RR respiratory rate
SNF skilled nursing facility
SOB shortness of breath
SpO2 O2 saturation by pulse oximeter
sz seizure
T1DM type 1 diabetes mellitus
T2DM type 2 diabetes mellitus
txp transplant
WHO World Health Organization